Oirschot, Netherlands

Frank Simonis

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Frank Simonis: Innovator in Blood Purification Technologies

Introduction

Frank Simonis is a notable inventor based in Oirschot, Netherlands. He has made significant contributions to the field of medical technology, particularly in the purification of blood and other biofluids. With a total of three patents to his name, Simonis has developed innovative devices aimed at improving health outcomes.

Latest Patents

One of Simonis's latest patents is a redox controlled electrosorption and decomposition device for the purification of blood and other fluids. This device is designed to remove various substances from blood, wastewater, and other biofluids. It features an electrocatalytic decomposition filter, an electrosorption filter, and a control system to prevent oxidative stress. Another significant invention is a device for the removal of toxic substances from blood. This device utilizes a sorption filter to eliminate toxins and toxic solutes from dialysate fluid, blood, or blood plasma, ensuring safer medical treatments.

Career Highlights

Throughout his career, Frank Simonis has worked with prominent organizations such as Nucletron B.V. and the Netherlands Organization for Applied Scientific Research (TNO). His experience in these companies has allowed him to refine his skills and contribute to groundbreaking advancements in medical technology.

Collaborations

Simonis has collaborated with notable professionals in his field, including Johann Kindlein and Evert Hendrik Agterhuis. These partnerships have facilitated the development of innovative solutions in blood purification technologies.

Conclusion

Frank Simonis stands out as a pioneering inventor in the realm of blood purification devices. His innovative patents and collaborations reflect his commitment to advancing medical technology for better health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…